Category: Cancer

Daratumumab, sold under the brand name Darzalex, is an anti-cancer monoclonal antibody medication. It binds to CD38,[2] which is overexpressed in multiple myeloma cells.[3] Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.[4] Daratumumab was granted breakthrough ... [wikipedia]

Dosage List

Darzalex Iv 100 mg/5ml Intravenous Injection, Solution, Concentrate
NDC: 57894-505
Janssen Biotech, Inc.

Related Brands

Drugs with the same active ingredients